Forge Biologics
Tuesday, June 04, 2024
Cell and Gene Therapy and Genome Editing
Company Presentation Theater 4
Forge Biologics, a member of Ajinomoto Biopharma Services, is a hybrid gene therapy contract manufacturing and clinical-stage therapeutics development company enabling access to life-changing gene therapies by bringing them from concept to reality. Forge’s 200,000 square foot facility, the Hearth, is headquartered in Columbus, Ohio, and houses 20 custom-designed cGMP suites. Forge’s end-to-end, scalable plasmid and AAV manufacturing services include research-grade manufacturing, process and analytical development, cGMP manufacturing, fill and finish, and regulatory consulting support to help accelerate the timelines of transformative medicines for patients with genetic diseases. To learn more, visit www.forgebiologics.com.
.png)
Company Website:
https://www.forgebiologics.com/
Lead Product in Development:
FBX-101, an AAV gene therapy for patients with Krabbe disease
Number Of Unlicensed Products (For Which You Are Seeking Partners):
n/a
Exchange
The Tokyo Stock Exchange / TYO
Ticker
AJINY
Company HQ City
Grove City
Company HQ State
Ohio
Company HQ Country
United States
CEO/Top Company Official
Timothy J. Miller
Development Phase of Primary Product
Phase I
Primary Speaker
)
)
)
)
)
)
){kind=logo}
){kind=logo}
.png/fit-in/500x500/filters:no_upscale())